Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The promise of artificial intelligence in diagnostic breast pathology.

Virchows Archiv : an international journal of pathology·2026
Same author

The potential use of artificial intelligence in reviewing atypical small acinar proliferation in prostate core biopsy.

Virchows Archiv : an international journal of pathology·2025
Same author

Breast Biomarker Cytology Practice in 2023: Results of a College of American Pathologists Survey.

Archives of pathology & laboratory medicine·2025
Same author

Malignant Phyllodes Tumor With Chondroblastic Osteosarcomatous Differentiation: A Case Report.

Cureus·2024
Same author

Exploring New Frontiers in the Role of Breast Pathologists in Breast Cancer.

Advances in anatomic pathology·2023
Same author

Is it Time to Retire the Term of Low-Grade Ductal Carcinoma in Situ and Replace it With Ductal Neoplasia?

Advances in anatomic pathology·2023

Related Experiment Video

Updated: Mar 27, 2026

A Multimodal Imaging Framework to Advance Phenotyping of Living Label-free Breast Cancer Cells
10:37

A Multimodal Imaging Framework to Advance Phenotyping of Living Label-free Breast Cancer Cells

Published on: August 22, 2025

1.4K

Breast cancer subtypes: morphologic and biologic characterization.

Shahla Masood1

  • 1Department of Pathology & Laboratory Medicine, University of Florida College of Medicine - Jacksonville, UF Health Breast Center, UF Health Jacksonville, 655 W. 8th Street, Box C-505, Jacksonville, FL 32209, USA.

Women'S Health (London, England)
|January 13, 2016
PubMed
Summary

Personalized breast cancer treatment relies on integrating clinical data, imaging, and biomarkers. Recognizing specific breast cancer subtypes and their biology is crucial for tailoring effective, individualized therapy.

Keywords:
breast cancer subtypesmolecular characterizationpersonalized medicine

More Related Videos

Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material
11:12

Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material

Published on: August 1, 2018

8.5K
Cancer-Associated Fibroblasts from Mouse Mammary Tumors as Tools for Molecular and Computational Studies
09:01

Cancer-Associated Fibroblasts from Mouse Mammary Tumors as Tools for Molecular and Computational Studies

Published on: July 3, 2025

1.1K

Related Experiment Videos

Last Updated: Mar 27, 2026

A Multimodal Imaging Framework to Advance Phenotyping of Living Label-free Breast Cancer Cells
10:37

A Multimodal Imaging Framework to Advance Phenotyping of Living Label-free Breast Cancer Cells

Published on: August 22, 2025

1.4K
Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material
11:12

Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material

Published on: August 1, 2018

8.5K
Cancer-Associated Fibroblasts from Mouse Mammary Tumors as Tools for Molecular and Computational Studies
09:01

Cancer-Associated Fibroblasts from Mouse Mammary Tumors as Tools for Molecular and Computational Studies

Published on: July 3, 2025

1.1K

Area of Science:

  • Oncology
  • Genetics
  • Medical Diagnostics

Background:

  • Recent advances in basic science, technology, and translational research have revolutionized breast cancer diagnosis and therapy.
  • Discoveries in gene variability and tumor heterogeneity are paving the way for personalized medicine in breast cancer care.
  • Effective personalized care requires integrating clinical information, risk factors, imaging, morphology, and prognostic/predictive testing.

Purpose of the Study:

  • To highlight the critical role of morphologic features and tumor biomarkers in patient outcomes.
  • To emphasize the importance of recognizing specific breast cancer subtypes for optimal personalized therapy design.

Main Methods:

  • Review of current scientific literature and research findings.
  • Analysis of the integration of diverse clinical and biological data points.
  • Focus on established morphologic features and tumor biomarkers.

Main Results:

  • The integration of clinical, imaging, and biomarker data enables identification of patients who benefit from specific therapies.
  • Understanding the link between breast cancer subtypes and their associated tumor biology is key.
  • Morphologic features and biomarkers are integral to predicting patient outcomes.

Conclusions:

  • Personalized breast cancer therapy necessitates a comprehensive approach, integrating various data sources.
  • Accurate identification of breast cancer subtypes and their underlying biology is essential for tailoring treatment.
  • Morphologic features and established biomarkers significantly influence patient outcomes in breast cancer.